Pathogenesis and Mechanisms of Mitral Annular Calcification

NCT04286009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2024-07-23

No results posted yet for this study

Summary

Researchers are testing blood or mitral valve tissue to better understand the reasons why Mitral Annular Calcification (MAC) develops in patients with heart disease.

Conditions

  • Mitral Annulus Calcification

Sponsors & Collaborators

Principal Investigators

  • Amir Lerman, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04286009 on ClinicalTrials.gov